Target intelligence / Profile preview

Cell-surface N-linked glycans bearing terminal galactose

Molecular classification
Glycan, Carbohydrate, Post-translational modification
01

Overview

Cell-surface N-linked glycans bearing terminal galactose are complex carbohydrate structures attached to the asparagine residues of membrane-bound proteins, characterized by a galactose sugar at the non-reducing end. These glycans serve as critical recognition elements in the biological landscape, acting as ligands for various endogenous receptors, most notably the asialoglycoprotein receptor (ASGPR) in the liver and the galectin family of proteins (Stockert, 1995; Cummings & Liu, 2009). Their primary biological roles include mediating the clearance of glycoproteins from the blood, facilitating cell-cell adhesion, and modulating immune system responses (Varki et al., 2015). In pathological conditions such as cancer and chronic inflammation, the expression patterns of these terminal galactose residues are often altered, contributing to disease progression, metastasis, and immune evasion (Pinho & Reis, 2015). From a therapeutic standpoint, these glycans are extensively exploited for targeted drug delivery; for instance, galactose and its derivatives are conjugated to therapeutic oligonucleotides to ensure precise uptake by hepatocytes via ASGPR (Springer & Dowdy, 2018). Furthermore, the interaction between these glycans and galectins is a target for novel inhibitors aimed at treating fibrosis and various malignancies (Johannes et al., 2018).

Other names
Terminal galactose N-glycansGalactosylated N-linked oligosaccharidesAsialoglycansβ-galactoside-terminated glycansTerminal Gal-terminated N-glycans
02

Mechanism of action

The primary mechanism involves the utilization of terminal galactose as a targeting ligand for the asialoglycoprotein receptor (ASGPR), which mediates the internalisation of conjugated therapeutic agents into hepatocytes via endocytosis. Additionally, therapeutic strategies involve the use of small molecules or polysaccharides to competitively inhibit the binding of terminal galactose residues to galectins, thereby disrupting pro-fibrotic and pro-inflammatory signaling cascades.

03

Biological functions

Cell-cell adhesionGlycoprotein clearanceSignal transductionImmune recognitionProtein trafficking
04

Disease associations

CancerLiver diseaseInflammationInfection
05

Safety considerations

Off-target binding to non-target lectinsRapid hepatic clearancePotential immunogenicity of synthetic glycan-conjugatesCompetition with endogenous glycoproteins
06

Interacting drugs

Belapectin (GR-MD-02)

4 more in the full profile.

07

Biomarkers

Serum asialoglycoprotein levelsGalectin-3 serum levelsAsialoglycoprotein receptor (ASGPR) expressionGlycan node analysisASGPR-targeted radiotracer imaging

Beyond the preview

Go deeper on Cell-surface N-linked glycans bearing terminal galactose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface N-linked glycans bearing terminal galactose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call